home / stock / lptx / lptx news


LPTX News and Press, Leap Therapeutics Inc. From 08/13/20

Stock Information

Company Name: Leap Therapeutics Inc.
Stock Symbol: LPTX
Market: NASDAQ
Website: leaptx.com

Menu

LPTX LPTX Quote LPTX Short LPTX News LPTX Articles LPTX Message Board
Get LPTX Alerts

News, Short Squeeze, Breakout and More Instantly...

LPTX - Leap Therapeutics EPS beats by $0.06, misses on revenue

Leap Therapeutics (NASDAQ: LPTX ) : Q2 GAAP EPS of -$0.12 beats by $0.06 . More news on: Leap Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

LPTX - Leap Therapeutics Reports Second Quarter 2020 Financial Results

CAMBRIDGE, Mass. , Aug. 13, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the second quarter ended June 30, 2020 . Leap Second Quarter Highlights...

LPTX - OPK, NBEV among premarket gainers

Immuron (NASDAQ: IMRN ) +114%  on potential of hyperimmune bovine antibodies in COVID-19. More news on: Immuron Limited, Midatech Pharma plc, New Age Beverages Corporation, , , Stocks on the move Read more ...

LPTX - Leap Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

CAMBRIDGE, Mass. , June 25, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing of an additional 3,375,000 shares of common stock pursuant to the full e...

LPTX - Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants

C AMBRIDGE , Mass., June 22, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing of a public offering of 20,250,000 shares of common stock and pre-funded warr...

LPTX - Leap Therapeutics under pressure after pricing equity offering

Thinly traded nano cap Leap Therapeutics (NASDAQ: LPTX ) prices its $45M public offering of common stock at $2 per share (also offering pre-funded warrants at $1.999 per warrant). More news on: Leap Therapeutics, Inc., Healthcare stocks news, , Stocks on the move, Read more ...

LPTX - Leap Therapeutics Announces Pricing of $45 Million of Common Stock and Pre-Funded Warrants

CAMBRIDGE, Mass. , June 18, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the pricing of an underwritten public offering of its common stock at a public offering price of...

LPTX - SSL, CCL among premarket losers

Francesca's Holdings (NASDAQ: FRAN )  -24%  on Q1 results . More news on: Francesca's Holdings Corporation, Medley Management Inc., Brickell Biotech, Inc., Stocks on the move, , Read more ...

LPTX - ADMS, ISEE, TMBR and LPTX among after-hours movers

Gainers:  ELOX +52.1% . ORN +17.7% . TMBR +8.5% . ABM +8.0% . DADA +7.2% . More news on: Eloxx Pharmaceuticals, Inc., Orion Group Holdings, Inc., Timber Pharmaceuticals, Inc., Stocks on the move, , Read more ...

LPTX - Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

CAMBRIDGE, Mass. , June 17, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has commenced an underwritten public offering of its common stock and, in lieu of c...

Previous 10 Next 10